期刊文献+

国产洛美沙星的体内抗菌作用研究 被引量:2

The antibacterial activity of lomefloxacin in vivo
下载PDF
导出
摘要 研究国产洛美沙星对3种致病菌感染的体内保护作用。小鼠灌胃洛美沙星对金黄色葡萄球菌感染的保护作用为诺氟沙星的3倍,环丙沙星的2倍;对大肠杆菌感染的保护作用是诺氟沙星的8倍,而略逊于环丙沙星;对绿脓杆菌的保护作用则是诺氟沙星的3~4倍,与环丙沙星相似或略差。小鼠静注洛美沙星亦表现明显的抗菌活性,并优于口服给药。结果显示,本品对3种细菌感染的保护作用明显优于诺氟沙星而具有良好的体内抗菌作用。 The antibacterial activity of LFLX in vivo was evaluated against 3 kinds of common bacteria isolated clinically and compared with the activities of NFLX and CPLX. In po groups, LFLX was about two times more active than NFLX and one time more active than CPLX against infections With S.aurens.The ED_(50) of LFLX against mice infected by S.aureus were 7.53,6.96mg·kg ̄(-1),respectively, LFLX was about six and seven times more active than NFLX against infections with two strains of E.coil, respectively, but its activity was lower than that of CPLX against E. coil. The ED_(50) of LFLX against mice infected by E.coil were 0.78 and 0.50 mg·kg ̄(-1), respectively. LFLX was about three times as active as NFLX against infections with two strains of Ps. aeruginosa. the activity of LFLX was similar to that of CPLX against one of two strains of P. aeruginosa, but lower than CPLX against another.The ED_(50) of LFLX against mice infected by Ps.aeruginosa were 9.05, 7.42 mg·kg ̄(-1),respectively. This study suggest that LFLX is a very effective antimicrobial agent.
出处 《中国药理学通报》 CAS CSCD 北大核心 1995年第2期151-154,共4页 Chinese Pharmacological Bulletin
关键词 洛美沙星 抗菌作用 ED50 抗感染药 lomefloxacin norfloxacin ciprofloxacin in vivo antibacterial activity 50% effective dose (ED_(50))
  • 相关文献

参考文献1

共引文献60

同被引文献16

  • 1刘德孟,朱宁,郝邯生,李立津,胡文芝,邱泽武,孔祥明,王淑范,方毅,黄英.国产盐酸洛美沙星治疗124例泌尿系感染[J].中国抗生素杂志,1994,19(4):264-267. 被引量:3
  • 2朱峰,张婴元.洛美沙星的临床评价[J].中国抗生素杂志,1994,19(4):259-263. 被引量:11
  • 3戴自英.实用内科学(第9版)[M].北京:人民卫生出版社,1992.1647.
  • 4林赴田.洛米沙星药理及临床[J].新药与市场,1990,(4):8.
  • 5中岛光好,植松俊彦,淹田祥会,et al.Fleroxacinの第一相临床试验Ⅰ[J].Chemotherapg,1990,(S-2):280.
  • 6[3]KVSAJMA H,Ishikawa N,Machida,et al.Pharmacokinetics of a new Quinolone,AM-833,InMics,Rates,Rabbits,Dogs and Monkeys[J].Antimicrob Ag Chemother,1986,30(2):304.
  • 7[4]Nakashima M,Kanamaru M,Uematsu T,et al.Clinical pharmacokinetics and tolerance of fleroxacin in healthy male volunteers[J].J Antimicrob Chem other,1988,22(Suppl D):133.
  • 8[5]Fernandes P B.Mode of action,and in vitro and in vivo activities of the fluoroquinolones[J].J Clin Pharmacol,1988,28:156-158.
  • 9Prosser BL, Beskid G. Multicenter in vitro comparative study of fluorquinolones againt 25,129 gram-positive and gramnegative clinical isolates, Diagn Microbial Infect Dis, 1995,21 (1):33.
  • 10Waiter K, Rand K . Yanga B . et al. Multicenter in vitro comparative study of fluoroquinolones after four years of widespread clinical use. Diagn Microbial Infect Dis, 1994,18(3): 181.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部